Pharmacy & Therapeutics - March 2008 - (Page 119) She couldn’t imagine her future without depression. But we can. Neuropharmacology & Neurophysiology | Neurodegeneration | Pain | Schizophrenia & Bipolar Disorder | Depression & Anxiety Wyeth Neuroscience believes that everyone deserves a healthier tomorrow. That’s why Wyeth is building one of the world’s leading pipelines focused on such challenging disease areas as depression, schizophrenia, bipolar disorder, Alzheimer’s disease, stroke, and pain. Our passion for research and development has produced innovative therapies that make a real difference for millions of patients. Wyeth will continue to develop new drugs that we hope will change the future of health care. Because every discovery brings new hope for patients everywhere. In addition to Wyeth.com, please visit a site dedicated entirely to neuroscience—WyethNeuroscience.com. © 2008, Wyeth Pharmaceuticals Inc., Philadelphia, PA 19101 219764-01 January 2008 http://WyethNeuroscience.com http://WyethNeuroscience.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.